Search

Search Results

• TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi

  e2023038

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.038

  2506

  PDF: 1936

  HTML: 1093

• THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

  Elvira Pelosi, Dr. Germana Castelli, Ugo Testa

  e2022080

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.080

  1741

  PDF: 1307

  HTML: 656

• MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.

  Maria Ilaria Del Principe

  e2016052

  2016-10-20

  https://doi.org/10.4084/mjhid.2016.052

  5268

  PDF: 1386

  HTML: 1947

  Untitled: 237

  Untitled: 223

• DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

  Sabina Chiaretti, Gina Zini, Renato Bassan

  e2014073

  2014-10-24

  https://doi.org/10.4084/mjhid.2014.073

  9582

  PDF: 6338

  HTML: 88331

  Fig.1b: 300

  Fig.1c: 302

  Fig.2a: 295

  Fig.2b: 265

  Fig.4: 316

  Fig.2c: 280

  Fig.3: 281

  Tab.1: 342

  Tab.2: 314

  Tab.3: 305

  Tab.4: 345

  Fig1a: 296

• ACUTE PROMYELOCYTIC LEUKEMIA: AN EXPERIENCE ON 95 GREEK PATIENTS TREATED IN THE ALL-TRANS-RETINOIC ACID ERA

  Maria Pagoni, Maria Garofalaki, Fotios Panitsas, Kalliopi Manola, Katerina Psarra, Panagiotis Economopoulos

  e2011053

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.053

  3019

  PDF: 981

  HTML: 3637

• TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS

  Luca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, Chiara Sarlo, Luigi Di Caprio, Concetta Ditto, Federica Giannotti, Daniela Nasso, Eleonora Ceresoli, Massimiliano Postorino, Marco Refrigeri, Sergio Amadori, Adriano Venditti

  e2013032

  2013-06-03

  https://doi.org/10.4084/mjhid.2013.032

  3112

  PDF: 1105

  HTML: 5674

• GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA

  Pouyan Kheirkhah, Ana M. Avila-Rodriguez, Bartlomiej Radzik, Carlos Murga-Zamalloa

  e2021067

  2021-10-29

  https://doi.org/10.4084/MJHID.2021.067

  1973

  PDF: 721

  HTML: 377

• ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

  Federico Lussana, Alessandro Rambaldi

  e2014065

  2014-10-20

  https://doi.org/10.4084/mjhid.2014.065

  3080

  PDF: 1364

  HTML: 2853

  Figure 1: 224

• ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: A SINGLE CENTRE EXPERIENCE FROM TURKEY

  Tekin Aksu

  e2018045

  2018-07-01

  https://doi.org/10.4084/mjhid.2018.045

  3141

  PDF: 1377

  HTML: 699

• CURRENT STRATEGIES FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

  Juliana Maria Camargos Rocha, Sandra Guerra Xavier, Marcelo Eduardo Lima Souza, Juliana Godoy Assumpção, Mitiko Murao, Benigna Maria Oliveira

  e2016024

  2016-04-10

  https://doi.org/10.4084/mjhid.2016.024

  4863

  PDF: 1425

  HTML: 4981

• AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY ACUTE MYELOID LEUKEMIA

  Gert J. Ossenkoppele, Jeroen J.W.M. Janssen, Peter C. Huijgens

  e2013018

  2013-02-16

  https://doi.org/10.4084/mjhid.2013.018

  2626

  PDF: 918

  HTML: 3290

• PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA

  Anna Falanga, Laura Russo, Carmen J Tartari

  e2011068

  2011-12-21

  https://doi.org/10.4084/mjhid.2011.068

  2039

  PDF: 911

  HTML: 10375

  Figures 1,2,3: 317

• CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi

  e2022069

  2022-08-27

  https://doi.org/10.4084/MJHID.2022.069

  3514

  PDF: 1030

  HTML: 4974

• MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA

  Melanie Joannides, Ashley N Mays, Anita R Mistry, Syed Khizer Hasan, Andreas Reiter, Joseph L Wiemels, Carolyn A Felix, Francesco Lo-Coco, Neil Osheroff, Ellen Solomon, David Grimwade

  e2011045

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.045

  3303

  PDF: 973

  HTML: 6631

  Untitled: 292

  Untitled: 247

  Untitled: 271

  Untitled: 274

• ACUTE PROMYELOCYTIC LEUKEMIA (APL): COMPARISON BETWEEN CHILDREN AND ADULTS

  Anna Maria Testi, Francesco Lococo

  e2014032

  2014-04-15

  https://doi.org/10.4084/mjhid.2014.032

  3083

  PDF: 1784

  HTML: 2385

• SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML

  Francesco D'Alò, Luana Fianchi, Emiliano Fabiani, Marianna Criscuolo, Mariangela Greco, Francesco Guidi, Livio Pagano, Giuseppe Leone, Maria Teresa Voso

  e2011052

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.052

  3893

  PDF: 991

  HTML: 6892

• NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms

  Gianfranco Catalano, Pasquale Niscola, Cristina Banella, Daniela Diverio, Malgorzata Monika Trawinska , Stefano Fratoni, Rita Iazzoni, Paolo de Fabritiis, Elisabetta abruzzese, Nelida Ines Noguera

  e2020083

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.083

  1935

  PDF: 1274

  HTML: 366

• PROGNOSTIC VALUE OF BRAIN AND ACUTE LEUKEMIA CYTOPLASMIC GENE EXPRESSION IN EGYPTIAN CHILDREN WITH ACUTE MYELOID LEUKEMIA

  adel abd elhaleim hagag

  e2015033

  2015-04-19

  https://doi.org/10.4084/mjhid.2015.033

  2277

  PDF: 898

  HTML: 1210

• OPTIMIZATION OF THE CLINICAL JOURNEY OF UNFIT PATIENTS WITH NEWLY DIAGNOSED IDH1M ACUTE MYELOID LEUKEMIA

  Adriano Venditti, Marta Riva, Livio Pagano, Giovanni Marconi, Nicola Fracchiolla, Romano Danesi, Antonio Curti, Anna Candoni, Erika Borlenghi, Maria Teresa Voso

  e2026086

  2026-10-31

  https://doi.org/10.4084/MJHID.2026.086

  72

  PDF: 45

  Html: 10

• TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS.

  Charicleia Kelaidi, Lionel Ades, Pierre Fenaux

  e2011038

  2011-09-08

  https://doi.org/10.4084/mjhid.2011.038

  3139

  PDF: 1044

  HTML: 2460

• PROGNOSIS AND THERAPY WHEN ACUTE PROMYELOCYTIC LEUKEMIA AND OTHER “GOOD RISK” ACUTE MYELOID LEUKEMIAS OCCUR AS A THERAPY-RELATED MYELOID NEOPLASM

  Richard A. Larson, Michelle Le Beau

  e2011032

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.032

  3126

  PDF: 1034

  HTML: 1895

• PHYSICIAN’S ATTITUDE TOWARDS TREATMENT OF OLDER PATIENTS AND THE CHOICE OF THERAPY

  Felicetto Ferrara

  e2013025

  2013-04-10

  https://doi.org/10.4084/mjhid.2013.025

  2517

  PDF: 874

  HTML: 1995

• MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY

  Francesco Lococo, Roberto Latagliata, Massimo Breccia

  e2013045

  2013-06-08

  https://doi.org/10.4084/mjhid.2013.045

  2962

  PDF: 1264

  HTML: 3331

• SPECTRUM AND IMMUNOPHENOTYPIC PROFILE OF ACUTE LEUKEMIA: A TERTIARY CENTER FLOW CYTOMETRY EXPERIENCE

  Nishit Gupta, Ravikiran Pawar, Sambhunath Banerjee, Subhajit Brahma, Asish Rath, Sundar Shewale, Mayur Parihar, Manish Singh, Arun SR, Shekhar Krishnan, Arpita Bhattacharyya, Anirban Das, Jeevan Kumar, Saurabh Bhave, Vivek Radhakrishnan, Reena nair, Mammen Chandy, Neeraj Arora, Deepak Kumar Mishra

  e2019017

  2019-02-26

  https://doi.org/10.4084/mjhid.2019.017

  3479

  PDF: 1742

  HTML: 492

• DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

  Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso

  e2022030

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.030

  1769

  HTML: 716

  PDF: 933

• ACUTE MYELOİD LEUKEMİA, MYELODYSPLASİA-RELATED: BEYOND CLASSİFİCATİON—TOWARD PRECİSİON DECİSİON-MAKİNG

  G Leone, U Testa, E Attardi, MT Voso

  e2026075

  2026-09-01

  https://doi.org/10.4084/MJHID.2026.075

  298

  PDF: 223

  Html: 156

• CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL

  Ugo Testa, Prof. Sica, Dr. Pelosi, Dr. Germana Castelli, Prof. Leone

  e2024010

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.010

  4806

  PDF: 3959

  HTML: 383

• GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE

  Francesco Fabozzi, Angela Mastronuzzi

  e2023032

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.032

  2238

  PDF: 596

  HTML: 635

• MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS

  Elena Maino, Anna Maria Scattolin, Piera Viero, Rosaria Sancetta, Anna Pascarella, Michele Vespignani, Renato Bassan

  e2015001

  2015-01-01

  https://doi.org/10.4084/mjhid.2015.001

  2518

  PDF: 1407

  HTML: 17236

  Bassan Fig.1: 187

  Bassan Fig.2: 292

  Bassan Fig.4: 175

  Fig.3: 305

• IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW

  Tomasz Sacha

  e2014007

  2013-12-31

  https://doi.org/10.4084/mjhid.2014.007

  5212

  PDF: 3020

  HTML: 2381

• ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THERAPY-RELATED MYELOID NEOPLASMS (t-MN) OF THE ADULT: MONOCENTRIC OBSERVATIONAL STUDY AND REVIEW OF THE LITERATURE.

  Elisabetta Metafuni, Patrizia Chiusolo, Luca Laurenti, Federica Sorà, Sabrina Giammarco, Andrea Bacigalupo, Giuseppe Leone, Simona Sica

  e2018005

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.005

  4371

  PDF: 1182

  HTML: 1460

• TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH SINGLE-AGENT ARSENIC TRIOXIDE

  Vikram Mathews, Ezhilarasi Chendamarai, Biju George, Auro Viswabandya, Alok Srivastava

  e2011056

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.056

  3857

  PDF: 1053

  HTML: 4646

• CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY

  Maria Ilaria Del Principe, Luca Maurillo, Francesco Buccisano, Giuseppe Sconocchia, Mariagiovanna Cefalo, Giovanna De Santis, Ambra Di Veroli, Concetta Ditto, Daniela Nasso, Massimiliano Postorino, Marco Refrigeri, Cristina Attrotto, Giovanni Del Poeta, Sergio Amadori, Adriano Venditti

  e2014075

  2014-11-01

  https://doi.org/10.4084/mjhid.2014.075

  4497

  PDF: 2057

  HTML: 5570

  Table 1: 300

• MOLECULAR MARKERS IN AML: PROGNOSTIC IMPLICATIONS AND IMPACT ON TREATMENT DECISION-MAKING

  Patrizia Chiusolo, Roberto Maggi, Angela Alessi, Simona Sica

  e2026087

  2026-10-31

  https://doi.org/10.4084/MJHID.2026.087

  72

  PDF: 39

  Html: 34

• INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER

  Caterina Giovanna Valentini, Luana Fianchi, Maria Teresa Voso, Morena Caira, Giuseppe Leone, Livio Pagano

  e2011069

  2011-12-22

  https://doi.org/10.4084/mjhid.2011.069

  3492

  PDF: 1055

  HTML: 3037

• BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL

  Ugo Testa, Elvira Pelosi, Germana Castelli, Patrizia Chiusolo

  e2024070

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.070

  1819

  PDF: 1178

  HTML: 200

• HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION

  Francesco Lo-Coco, Laura Cicconi

  e2011067

  2011-12-21

  https://doi.org/10.4084/mjhid.2011.067

  3388

  PDF: 1200

  HTML: 2015

• PROGNOSTIC SIGNIFICANCE OF TRANSCRIPT-TYPE BCR/ABL1 IN CHRONIC MYELOID LEUKEMIA

  matteo molica, elisabetta abruzzese, massimo breccia

  e2020062

  2020-09-12

  https://doi.org/10.4084/mjhid.2020.062

  4367

  PDF: 1731

  HTML: 882

• ALLOGENEIC TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA IN THE ERA OF NOVEL THERAPIES: CHANGING INDICATIONS AND DYNAMIC RISK ASSESSMENT

  Simona Sica, Filippo Frioni, Matteo Breccia, Patrizia Chiusolo

  e2026088

  2026-10-31

  https://doi.org/10.4084/MJHID.2026.088

  52

  PDF: 53

  Html: 24

• FLT3 INTERNAL TANDEM DUPLICATION AND D835 MUTATIONS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND ITS CLINICAL SIGNIFICANCE

  Ghaleb Elyamany, Mohamed Awad, Omar Alsuhaibani, Kamal Fadalla, Omer Al Sharif, Mohammad Al Shahrani, Fahad Alabbas, Abdulaziz Al-Abulaaly

  e2014038

  2014-05-30

  https://doi.org/10.4084/mjhid.2014.038

  2019

  PDF: 1043

  HTML: 7322

• EPIDEMIOLOGY AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN LATIN AMERICA

  Eduardo Magalhães Rego, Rafael Henriques Jácomo

  e2011049

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.049

  2852

  PDF: 1165

  HTML: 2593

• ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia

  Gabriele Magliano, Andrea Bacigalupo

  e2020081

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.081

  1931

  PDF: 583

  HTML: 369

• HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation

  Anna Maria Testi

  e2022038

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.038

  1440

  PDF: 937

  HTML: 279

• PROGNOSTIC SIGNIFICANCE OF NRAS GENE MUTATIONS IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA

  Rabab Aly, Mohamed R. El-sharnoby, Adel A. Hagag

  e2011055

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.055

  1998

  PDF: 838

  HTML: 1588

• DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA

  Juan Eduardo Megias-Vericat, David Martínez-Cuadrón, Joaquin Martínez López, Juan Miguel Bergua, Mar Tormo, Josefina Serrano, Ataulfo González, Jaime Pérez de Oteyza, Susana Vives, Belen Vidriales, Pilar Herrera, Juan Antonio Vera, Aurelio López Martínez, Adolfo De la Fuente, María Lourdes Amador, José Ángel Hernández-Rivas, María Ángeles Fernández, Carlos Javier Cerveró, Daniel Morillo, Pilar Hernández Campo, Julián Gorrochategui, Daniel Primo, José Luis Rojas, Margarita Guenova, Joan Ballesteros, Miguel Ángel Sanz, Pau Montesinos

  e2019016

  2019-02-26

  https://doi.org/10.4084/mjhid.2019.016

  2189

  PDF: 1218

  HTML: 336

• EXTRAMEDULLARY DISEASE IN ACUTE PROMYELOCYTIC LEUKEMIA: TWO-IN-ONE DISEASE

  Francesco Albano, Giorgina Specchia

  e2011066

  2011-12-21

  https://doi.org/10.4084/mjhid.2011.066

  4966

  PDF: 960

  HTML: 2962

• THE DIFFERENTIATION SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: EXPERIENCE OF THE PETHEMA GROUP AND REVIEW OF THE LITERATURE.

  Pau Montesinos, Miguel A Sanz

  e2011059

  2011-12-04

  https://doi.org/10.4084/mjhid.2011.059

  3505

  PDF: 1672

  HTML: 3052

• LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML

  Xavier Thomas, Marica Laurino, sandrine loron, marie-virginie larcher, gaëlle fossard, mohamed elhamri, alexandre deloire, marie balsat, fiorenza barraco, hélène labussière, sophie ducastelle, myriam renault, eric wattel, maël heiblig, gilles salles

  e2020020

  2020-04-27

  https://doi.org/10.4084/mjhid.2020.020

  2046

  PDF: 1264

  HTML: 352

• THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition

  Emiliano Fabiani, Dr. Falconi, Dr. Cristiano, Dr. Hajrullaj, Dr. Falconi, Prof. Leone, Prof. Voso

  e2023064

  2023-10-30

  https://doi.org/10.4084/MJHID.2023.064

  1648

  PDF: 1036

  HTML: 271

• THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA

  Francesca Ricci, Alessandra Tedeschi, Marco Montillo, Enrica Morra

  e2011031

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.031

  2488

  PDF: 1048

  HTML: 2513